Late relapse of metastatic non-seminomatous testicular germ cell tumours

Clinical Radiology

Volumn 61, Issue 11, 2006, Pages 907-915

  Rutherford, E E ^a   Ferguson, J L ^a   Geldart, T R ^b   Mead, G M ^b   Smart, J M ^a   Tung, K T ^a  

^a Institute of Radiology Department   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FOLLOW UP; GERM CELL TUMOR; HUMAN; INGUINAL LYMPH NODE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MUSCLE METASTASIS; PERITONEUM METASTASIS; PLEURA METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSOAS MUSCLE; RETROPERITONEAL CANCER; REVIEW; SPLEEN CANCER; TERATOMA;

DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEOPLASMS, GERM CELL AND EMBRYONAL; POSITRON-EMISSION TOMOGRAPHY; TESTICULAR NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749080047     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2006.06.009     Document Type: Review

References (46)

1. Williams S.D., Birch R., Einhorn L.H., et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316 (1987) 1435-1440
2. Cancer facts and figures 2003. American Cancer Society Inc., 2003. Detailed guide: testicular cancer. http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_what_is_testicular_cancer_41.asp.
3. In: Pugh R.C.B. (Ed). Pathology of the testes (1976), Blackwell Scientific, Oxford
4. Read G., Stenning S.P., Cullen M.H., et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumours Working Party. J Clin Oncol 10 (1992) 1762-1768
5. Sogani P.C., Perrotti M., Herr H.W., et al. Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol 159 (1998) 855-858
6. Hermans B.P., Sweeney C.J., Foster R.S., et al. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumour managed by retroperitoneal lymph node dissection. J Urol 163 (2000) 1721-1724
7. Shahidi M., Norman A.R., Dearnaley D.P., et al. Late recurrence in 1263 men with testicular germ cell tumours. Multivariate analysis of risk factors and implications for management. Cancer 95 (2002) 520-530
8. Gerl A., Clemm C., Schmeller N., et al. Late relapse of germ cell tumours after cisplatin-based chemotherapy. Ann Oncol 8 (1997) 41-47
9. Baniel J., Foster R.S., Gonin R., et al. Late relapse of testicular cancer. J Clin Oncol 13 (1995) 1170-1176
10. Lipphardt M.E., and Albers P. Late relapse of testicular cancer. World J Urol 22 (2004) 47-54
11. George D.W., Foster R.S., Hromas R.A., et al. Update on late relapse of germ cell tumour: a clinical and molecular analysis. J Clin Oncol 21 (2003) 113-122
12. Dieckmann K.P., Albers P., Classes J., et al. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. J Urol 173 (2005) 824-829
13. Geldart TG, Gale J, McKendrick J, et al. Late relapse of metastatic testicular non-seminomatous germ cell cancer: surgery needed for cure. BJU Int; in press.
14. Terebelo H.R., Taylor H.G., Brown A., et al. Late relapse of testicular cancer. J Clin Oncol 1 (1983) 566-571
15. Maatman T., Bukowski R.M., and Montie J.E. Retroperitoneal malignancies several years after initial treatment of germ cell cancer of the testis. Cancer 54 (1984) 1962-1965
16. Schmoll H.J., Souchon R., Krege S., et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15 (2004) 1377-1399
17. Michael H., Lucia J., Foster R.S., et al. The pathology of late recurrence of testicular germ cell tumours. Am J Surg Pathol 24 (2000) 257-273
18. Tait D., Peckham M.J., Hendry W.F., et al. Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 50 (1984) 601-609
19. Logothetis C.J., Samuels M.L., Trindade A., et al. The growing teratoma syndrome. Cancer 50 (1982) 1629-1635
20. Jefferey G.M., Theaker J.M., Lee A.H.S., et al. The growing teratoma syndrome. Br J Urol 67 (1991) 195-202
21. Simmonds P.D., Lee A.H., Theaker J.M., et al. Primary pure teratoma of the testis. J Urol 155 (1996) 939-942
22. The Royal College of Radiologists' Clinical Oncology Information Network in partnership with the Scottish Intercollegiate Guidelines Network. Guidelines on the management of adult testicular germ cell tumours. Produced by representatives of the Clinical Oncology Information Network and the Scottish Intercollegiate Guidelines Network. Version 2:2000.
23. Mead G.M., Rustin G.J., Stenning S.P., et al. Medical Research Council trial of 2 versus 5 CT scans in the surveillance of patients with stage I non-seminomatous germ cell tumours of the testis (Abstract) 2006 Annual Meeting Proceedings part I. J Clin Oncol 24 18S (2006) 4519
24. DeLeo M.J., Grecco A., Hainsworth J.D., et al. Late recurrences in long-term survivors of germ cell neoplasms. Cancer 62 (1988) 985-988
25. Ravi R., Oliver R., Ong J., et al. A single-centre observational study of surgery and late malignant events after chemotherapy for germ cell cancer. Br J Urol 80 (1997) 647-652
26. Mead G.M., Stenning S.P., Parkinson M.C., et al. The second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumours. Medical Research Council Testicular Tumour Working Party. J Clin Oncol 10 (1992) 85-94
27. Loehrer P.J., Williams S.D., and Einhorn L.H. Testicular cancer: the quest continues. J Natl Cancer Inst 80 (1988) 1373-1382
28. Husband J.E., and Koh D. Testicular germ cell tumours. In: Husband J.E., and Reznek R.H. (Eds). Imaging in oncology. 2nd ed. (2004), Taylor and Francis, London p. 401-27.
29. Dixon A.K., Ellis M., and Sikora K. Computed tomography of testicular tumours: distribution of abdominal lymphadenopathy. Clin Radiol 37 (1986) 519-523
30. MacVicar D. Staging of testicular germ cell tumours. Clin Radiol 47 (1993) 149-158
31. Wood A., Robson N., Tung K., et al. Patterns of supradiaphragmatic metastases in testicular germ cell tumours. Clin Radiol 51 (1996) 273-276
32. Carver B.S., Motzer R.J., Kondagunta G.V., et al. Late relapse of testicular germ cell tumours. Urol Oncol 23 (2005) 441-446
33. Rouvière H. Anatomy of the human lymphatic system (1938), Edwards Brothers, Ann Arbor (translation by Tobias MJ)
34. Williams M.P., Cook J.V., and Duchesne G.M. Psoas nodes: an overlooked site of metastasis from testicular tumours. Clin Radiol 40 (1989) 607-609
35. Copson E., McKendrick J., Hennessy N., et al. Liver metastases in germ cell cancer: defining a role for surgery after chemotherapy. BJU Int 94 (2004) 552-558
36. Husband J.E., and Bellamy E.A. Unusual thoracoabdominal sites of metastases in testicular tumours. AJR Am J Roentgenol 145 (1985) 1165-1171
37. Cook A.M., and Graham J.D. Spontaneous rupture of the spleen secondary to metastatic teratoma. J R Soc Med 89 (1996) 710
38. Barakos J.A., Brookefeffrey R., Mccaninch J.W., et al. CT diagnosis of diffuse intraperitoneal metastatses after retroperitoneal lymphadenectomy for testicular carcinoma. J Urol 136 (1986) 680-681
39. Heafield R.J., Mead G.M., and Tung K.T. Intraperitoneal metastases from testicular germ cell tumour. Br J Radiol 67 (1994) 501-503
40. McKinna F.E., Matthews P.N., and Mason M.D. An unusual late relapse of metastatic non-seminomatous germ cell tumour. Clin Oncol 6 (1994) 407-408
41. Bilgrami S., Chen L., Shafi N., et al. An unusual late relapse in pathologic stage I non-seminomatous germ cell tumour: case report and review of the literature. Urol Int 53 (1994) 176-178
42. Cemerius U., Wildberger J.E., Borchers H., et al. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? Results of a study in 50 patients. Urology 53 (1999) 808-811
43. Lassen U., Daugaard G., Eigtved A., et al. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Eur J Nucl Med Mol Imaging 30 (2003) 396-402
44. Hain S.F., O'Doherty M.J., Timothy A.R., et al. Fluoro-deoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 83 (2000) 863-869
45. 18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse. BJU Int 89 (2002) 912-916
46. Stephens A.W., Gonin R., Hutchins G.D., et al. Positron emission tomography evaluation of residual radiographic abnormalities in post-chemotherapy germ cell tumour patients. J Clin Oncol 14 (1996) 1637-1641